Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology
1. AMIX granted European patent for neuromodulation technology. 2. Patent covers systems for regulating tumor growth and nerve activity. 3. Plans to submit IDE for U.S. clinical trials in 2025. 4. Technology aims to treat pancreatic cancer pain and other conditions. 5. Expanding patent portfolio strengthens future application potential.